Phosphorylated Morpholine Acetal Human Neurokinin-1 Receptor Antagonists as Water-Soluble Prodrugs
- 25 February 2000
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 43 (6), 1234-1241
- https://doi.org/10.1021/jm990617v
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Substance P‐induced vasodilatation is mediated by the neurokinin type 1 receptor but does not contribute to basal vascular tone in manBritish Journal of Clinical Pharmacology, 1999
- Reduction of Cisplatin-Induced Emesis by a Selective Neurokinin-1–Receptor AntagonistThe New England Journal of Medicine, 1999
- ANTIEMETIC ACTIVITY OF THE NK1 RECEPTOR ANTAGONIST GR205171 IN THE TREATMENT OF PONV FOLLOWING MAJOR GYNAECOLOGICAL SURGERYAnesthesia & Analgesia, 1998
- COMPARISON OF A NEW NK-1 ANTAGONIST (CP122,721) TO ONDANSETRON IN THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITINGAnesthesia & Analgesia, 1998
- Improved oral drug delivery: solubility limitations overcome by the use of prodrugsAdvanced Drug Delivery Reviews, 1996
- Towards Understanding the Aetiology and Pathophysiology of the Emetic Reflex: Novel Approaches to Antiemetic DrugsOncology, 1996
- Prodrugs for the improvement of drug absorption via different routes of administrationEuropean Journal of Drug Metabolism and Pharmacokinetics, 1990
- The molecular biology of receptors: Techniques and application of receptor research: Edited by A. D. Strosberg, VCH and Ellis Horwood, 1987, £36.45/DM.105 (235 pages) ISBN 0 89573 558 XTrends in Pharmacological Sciences, 1988
- Salt selection for basic drugsInternational Journal of Pharmaceutics, 1986
- Pharmaceutical SaltsJournal of Pharmaceutical Sciences, 1977